1/29
07:04 pm
vivs
VivoSim Expands Asia-Pacific Access to NAMKind™ Human-Based Toxicology Services Through New Distributor Agreement in Korea and China [Yahoo! Finance]
High
Report
VivoSim Expands Asia-Pacific Access to NAMKind™ Human-Based Toxicology Services Through New Distributor Agreement in Korea and China [Yahoo! Finance]
1/29
04:05 pm
vivs
VivoSim Expands Asia-Pacific Access to NAMKind™ Human-Based Toxicology Services Through New Distributor Agreement in Korea and China
High
Report
VivoSim Expands Asia-Pacific Access to NAMKind™ Human-Based Toxicology Services Through New Distributor Agreement in Korea and China
1/23
05:09 am
vivs
VivoSim Labs (NASDAQ:VIVS) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Medium
Report
VivoSim Labs (NASDAQ:VIVS) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
1/6
08:05 am
vivs
VivoSim Labs Appoints Amar Sethi, M.D., Ph.D. as Chief Scientific Officer
Low
Report
VivoSim Labs Appoints Amar Sethi, M.D., Ph.D. as Chief Scientific Officer
11/11
06:49 am
vivs
3D Bioprinting Market Size to Surpass USD 8.57 Billion by 2034 [Yahoo! Finance]
Low
Report
3D Bioprinting Market Size to Surpass USD 8.57 Billion by 2034 [Yahoo! Finance]